Status:
COMPLETED
Evaluation of the EpiGlare Tester for the Measurement of Glare-Induced Changes in BSCVA in Subjects With and Without Cataracts
Lead Sponsor:
Epico, LLC
Conditions:
Cataract
Eligibility:
All Genders
18+ years
Brief Summary
The EpiGlare Tester will identify visual disability resulting from the glare experienced by subjects with cataracts in the glare-induced change in best spectacle corrected visual acuity (BSCVA).
Detailed Description
Inclusion Criteria: 1. Are 18 years of age or older. 2. Have been evaluated by an opthalmologist and have a lens determination of either Normal or Cataract in each eye based on slit lamp examination....
Eligibility Criteria
Inclusion
- clear lenses OU cataracts OU willing to comply with testing
Exclusion
- BCVA \< 20/63 either eye ocular pathology (ie corneal, macular disease, advanced glaucoma) cognitive dysfunction other conditions that in the investigators opinion made the subject unsuitable candidate
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT04739397
Start Date
November 1 2011
End Date
June 1 2013
Last Update
February 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Eye Center of Columbus
Columbus, Ohio, United States, 43215